Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
The American Journal of Medicine|December 17, 2005
Lipid-lowering therapy and the patient with multiple risk factors: what have we learned from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)?Peter S SeverBlood Pressure|April 21, 2017
Improving Antihypertensive Efficacy while Maintaining Placebo-like TolerabilityPeter S SeverJournal of Human Hypertension|February 28, 2020
Correction: The importance of a valid assessment of salt intake in individuals and populations. A scientific statement of the British and Irish Hypertension SocietyFrancesco P Cappuccio, Peter S Sever, European Heart Journal|June 24, 2011
Hypertension management 2011: optimal combination therapyPeter S Sever, Franz H MesserliJournal of the Renin-Angiotensin-Aldosterone System : JRAAS|June 9, 2009
Managing cardiovascular and renal risk: the potential of direct renin inhibitionPeter S Sever, Alan H Gradman, Michel AziziInternational Journal of Cardiology|June 16, 2009
Calcium channel regulation in vascular smooth muscle cells: synergistic effects of statins and calcium channel blockersGerard F Clunn, Peter S Sever, Alun D HughesJournal of Hypertension|March 26, 2009
Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extensionPeter S Sever, Neil R Poulter, Bjorn Dahlof, et al.The American Journal of Cardiology|August 30, 2005
Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)Peter S Sever, Neil R Poulter, Björn Dahlöf, et al.Diabetes Care|April 24, 2010
Metabolic syndrome, independent of its components, is a risk factor for stroke and death but not for coronary heart disease among hypertensive patients in the ASCOT-BPLAAjay K Gupta, Bjorn Dahlof, Peter S Sever, et al.JAMA Internal Medicine|May 29, 2019
Association of Nonfasting vs Fasting Lipid Levels With Risk of Major Coronary Events in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering ArmSamia Mora, C Lan Chang, M Vinayaga Moorthy, et al.Pageof 9